Answers are grounded in this paper and cite their sources.
Polycystic ovary syndrome (PCOS) is the most common chronic endocrine disease in women. The prevailing complaints at a young age are menstrual irregularities, infertility, and hyperandrogenism-related problems. However, metabolic disorder-induced complications have been in the foreground over years. The review gives the current ideas on a change of clinical manifestations in the natural course of PCOS, as well as the pathogenetically grounded prevention of complications in patients.
No takes yet. Share an insight, caveat, or question.
Grigoryan et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: